[1]
S. Agop, “The first data on international multicenter clinical study RheoSTAT-CP0691 on the efficacy and safety of Rheosorbilact® infusion in therapy of purulent peritonitis”, prmd, vol. 5, no. 1, pp. 34–46, May 2022.